arrow_back Back Filing freshness 10-Q FY 2025 SEC EDGAR

NEPHROS INC

NEPH
$3.60 ▲ +0.07 (+1.98%) at close
Healthcare ·Surgical & Medical Instruments & Apparatus ·USSurgical & Medical Instruments & Apparatus
17 Visible periods
31 Metrics
Peer-ranked Benchmarks
Price Chart
74
Health
Good
Neutral
auto_awesome

Analytical Summary

NEPHROS INC shows mixed fundamentals. Consider comparing against peers in the Healthcare sector before making investment decisions.

Market Cap $38.2M
Dividend Yield
Revenue Growth 32.7%
Op. Margin 6.1%
ROIC None
FCF / Share $0.16
Trailing P/E 32.7x
Price / Book
FCF Yield 4.3%
Debt / Equity
info Valuation on last close. End-of-day price, Aug 6, 2026.

17-Year Financial Trajectory

Annual
Metric Value Trend Year over Year Percentile
Revenue Total top-line sales
$18.79M
↑ +32.7%
Net Income Profit after all expenses
$1.19M
↑ +1513.5%
Operating Margin Operating profit as % of sales
6.1%
↑ +14296.4% 46th
FCF / Share Free cash flow per share
$0.16
↑ +398.3%
Long-Term Debt Long-term obligations
$71.00K
↓ -88.0%

Health Breakdown

Profitability
52
Financial Health
99
Cash Quality
78

bar_chart Data from SEC EDGAR XBRL filings

Synced 1 week ago 17 years · 65 quarters